Loading clinical trials...

COMPLETEDNA

Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals

Randomized Clinical Trial to Evaluate the Efficacy of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals

NCT05758363•Universidad Católica San Antonio de Murcia

View on ClinicalTrials.gov

Summary

The aim of this randomized, parallel, two-arm, placebo-controlled, double-blind, multicenter clinical trial is to evaluate the efficacy of a dietary supplement on weight loss and psychological well-being in overweight individuals.

Detailed Description

The duration of the study will be 6 months during which the investigational product or placebo will be consumed according to the assignment. Subjects will be randomized to each of the study arms (consumption of the experimental product or control product).

Eligibility

Age

30 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Adults (age: 30 - 70 YO)
•BMI over 25 kg/m2.
•Subjects who are smokers or non-smokers, but in any case who do not modify their nicotinic habits during their participation in the study.

Exclusion Criteria

•Subjects with eating disorders.
•BMI less than 25 Kg/m2.
•History of allergic hypersensitivity or poor tolerance to any component of the products under study.
•Participation in another clinical trial in the three months prior to the study.
•Unwillingness or inability to comply with clinical trial procedures.
•Pregnant woman.
•Participants with an active daily exercise activity.
•Subjects whose condition makes them ineligible for the study at the investigator's discretion.

Locations (1)

UCAM San Antonio Catholic University of Murcia

Murcia, Spain

Key Dates

Start Date

March 9, 2023

Primary Completion Date

September 30, 2023

Completion Date

November 30, 2023

Last Updated

March 20, 2024

Enrollment

ACTUAL participants

Conditions

Overweight

Interventions

Consumption of dietary supplement.

DIETARY_SUPPLEMENT

Consumption of control product

OTHER

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

NCT07472881

MenopausePerimenopause+2 more

View study

RECRUITINGNA

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

NCT07237750

Overweight and/or ObesityMetabolic Syndrome+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 20, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight Individuals

Inclusion Criteria

Exclusion Criteria

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Effects of Cranberry on Gut and Metabolic Health

Personalizing Financial Incentives

High Phenolic Olive Oil for Enhancing Metabolic Health: a Randomized-controlled Trial in Patients With cEntral Obesity (HOPE)

Adherence to an Exercise Program and Pre- and Post-Changes After Bariatric Surgery